Not all pediatric intestinal polyps are alike.


Journal

Acta gastro-enterologica Belgica
ISSN: 1784-3227
Titre abrégé: Acta Gastroenterol Belg
Pays: Belgium
ID NLM: 0414075

Informations de publication

Date de publication:
Historique:
entrez: 23 10 2020
pubmed: 24 10 2020
medline: 30 10 2020
Statut: ppublish

Résumé

In childhood, clinical presentation of intes- tinal polyps is variable. Painless rectal red blood loss is the most common presenting sign. Most polyps are sporadic, isolated and benign. However, it is important to correctly identify exceptions. Rare inherited polyposis syndromes need to be recognized because of their increased risk of intestinal and extra-intestinal malignancies. Furthermore, a correct diagnosis and treatment of rare gastro-intestinal malignancies is crucial. Between 2016 and 2018 we encountered 4 different types of intestinal polyps. A database search was performed and patient files were checked for clinical manifestations and histo- pathology. Literature was searched to recapitulate red flags for these syndromes, probability of underlying genetic disorders and diagnostic criteria. Between 2016 and 2018, 28 patients presented at the Ghent University Hospital with 30 juvenile polyps. Furthermore, we diagnosed juvenile polyposis syndrome, Li Fraumeni syndrome and familial adenomatous polyposis (FAP) in 1 patient each, whilst 2 FAP patients were in follow-up. Each of these diagnoses has a different lifetime risk of (extra)-intestinal malignancy and requires a different approach and follow-up. Histopathology and genetic testing play an important role in identifying these syndromes in pediatric patients. Although most intestinal polyps in childhood are benign juvenile polyps that require no follow-up, rare inherited syndromes should be considered and correctly diagnosed since adequate follow-up is necessary to reduce morbidity and mortality from both gastrointestinal and extraintestinal complications and malignancies.

Sections du résumé

BACKGROUND/AIMS OBJECTIVE
In childhood, clinical presentation of intes- tinal polyps is variable. Painless rectal red blood loss is the most common presenting sign. Most polyps are sporadic, isolated and benign. However, it is important to correctly identify exceptions. Rare inherited polyposis syndromes need to be recognized because of their increased risk of intestinal and extra-intestinal malignancies. Furthermore, a correct diagnosis and treatment of rare gastro-intestinal malignancies is crucial.
METHODS METHODS
Between 2016 and 2018 we encountered 4 different types of intestinal polyps. A database search was performed and patient files were checked for clinical manifestations and histo- pathology. Literature was searched to recapitulate red flags for these syndromes, probability of underlying genetic disorders and diagnostic criteria.
RESULTS RESULTS
Between 2016 and 2018, 28 patients presented at the Ghent University Hospital with 30 juvenile polyps. Furthermore, we diagnosed juvenile polyposis syndrome, Li Fraumeni syndrome and familial adenomatous polyposis (FAP) in 1 patient each, whilst 2 FAP patients were in follow-up. Each of these diagnoses has a different lifetime risk of (extra)-intestinal malignancy and requires a different approach and follow-up. Histopathology and genetic testing play an important role in identifying these syndromes in pediatric patients.
CONCLUSION CONCLUSIONS
Although most intestinal polyps in childhood are benign juvenile polyps that require no follow-up, rare inherited syndromes should be considered and correctly diagnosed since adequate follow-up is necessary to reduce morbidity and mortality from both gastrointestinal and extraintestinal complications and malignancies.

Identifiants

pubmed: 33094585

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

393-397

Informations de copyright

© Acta Gastro-Enterologica Belgica.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest

Auteurs

D Vermeulen (D)

Pediatrics, Ghent University Hospital, Ghent, Belgium.

M Van Winckel (M)

Pediatric gastroenterology, Ghent University Hospital, Ghent, Belgium.

S Vande Velde (S)

Pediatric gastroenterology, Ghent University Hospital, Ghent, Belgium.

R De Bruyne (R)

Pediatric gastroenterology, Ghent University Hospital, Ghent, Belgium.

S Van Biervliet (S)

Pediatric gastroenterology, Ghent University Hospital, Ghent, Belgium.

B De Moerloose (B)

Pediatric hemato-oncology and stem cell transplantation, Ghent University Hospital, Ghent, Belgium.

L Matthyssens (L)

Gastrointestinal and pediatric surgery, Ghent University Hospital, Ghent, Belgium.

K Van Renterghem (K)

Gastrointestinal and pediatric surgery, Ghent University Hospital, Ghent, Belgium.

D Vandeputte (D)

Gastrointestinal and pediatric surgery, Ghent University Hospital, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH